JPS6244905B2 - - Google Patents
Info
- Publication number
- JPS6244905B2 JPS6244905B2 JP60149725A JP14972585A JPS6244905B2 JP S6244905 B2 JPS6244905 B2 JP S6244905B2 JP 60149725 A JP60149725 A JP 60149725A JP 14972585 A JP14972585 A JP 14972585A JP S6244905 B2 JPS6244905 B2 JP S6244905B2
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- weight
- linolenic acid
- parts
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 20
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 20
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 20
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 17
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 17
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 17
- 229960002733 gamolenic acid Drugs 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 16
- 229920000858 Cyclodextrin Polymers 0.000 description 9
- 230000000694 effects Effects 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000008524 evening primrose extract Nutrition 0.000 description 3
- 229940089020 evening primrose oil Drugs 0.000 description 3
- 239000010475 evening primrose oil Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
〔産業上の利用分野〕
本発明は痩身用食品に関する。
〔従来の技術〕
サイクロデキストリンにはその分子構造上の差
異から３種の異性体が存在し、更に詳しくはα−
サイクロデキストリン、β−サイクロデキストリ
ン並びにγ−サイクロデキストリンの３種の異性
体が存在する。これ等サイクロデキストリンは古
くから食品用の素材として使用されて来ており、
特にβ−サイクロデキストリンはその包接作用に
基づく各種の用途、たとえば味覚改良材や粉末ア
ルコール等に利用されている。しかしながらこの
β−サイクロデキストリンは消化性物質で人体の
小腸から吸収されるために栄養過多となる傾向が
あり、痩身用食品の素材としては極めて不向きな
ものである。
而して最近サイクロデキストリンの１種たるγ
−サイクロデキストリンは人の消化酵素によつて
は消化され難い性質を有することが見出され、痩
身用食品の素材として使用出来る可能性のあるこ
とが発表された。そして引き続きこのα−サイク
ロデキストリンが消化器官内にて特異選択的に遊
離脂肪酸を吸着し排泄する作用を有することも見
出されるに至つた。
一方γ−リノレン酸は脂肪代謝作用を有する物
質として古くから良く知られており、その他たち
えばコレステロール値と血圧の調整等にも有効で
ある等各種の健康維持に好適な物質として知られ
ている。
〔発明の目的並びに概要〕
本発明者は従来から痩身用食品について研究を
続けて来たが、この研究に於いて各種の肥満防止
に有効な数多くの化合物のうち、特にα−サイク
ロデキストリンとγ−リノレン酸とを併用する場
合はこれ等の相乗作用により著しく優れた肥満乃
至体重増加防止効果を発揮することを見出し、痩
身用食品として極めて好適なものであることを確
認し、ここに本発明を完成するに至つた。即ち本
発明は、α−サイクロデキストリンとγ−リノレ
ン酸とを含有して成る痩身用食品に係るものであ
る。
〔発明の構成〕
本発明の痩身用食品はα−サイクロデキストリ
ンとγ−リノレン酸とを好ましくは前者100重量
部に対して後者0.5〜10重量部、特に好ましくは
３〜４重量部含有して成るものである。
本発明に於いて使用されるα−サイクロデキス
トリンとしては従来から知られているものがいず
れも使用出来る。このα−サイクロデキストリン
はこれを単独で使用しても良く、またこれを含有
する素材を使用しても良い。
本発明に於いて使用されるγ−リノレン酸とし
てもこれを単独で使用しても良く、またこれを含
有する成分乃至物質たとえば月見草油等を使用し
ても良い。
本発明に於いては上記２種類の化合物を併用す
ることを必須とし、これ等両者の相乗作用により
著しく優れた肥満防止乃至体重増加防止効果を発
揮する。この相乗作用は特にα−サイクロデキス
トリン100重量部に対しγ−リノレン酸0.5〜10重
量部特に好ましくは３〜４重量部の割合で発揮さ
れる。この優れた相乗作用は後記実験例からも極
めて明らかである。
本発明に於いてはα−サイクロデキストリンと
γ−リノレン酸とを所定の割合で各種の食品また
は食品添加材に含有させるか、またはこれ等両者
を必要に応じ従来公知の各種の添加材と共に適当
な形状たとえば錠剤、丸剤、顆粒状に成形しても
良い。含有させるべき食品乃至食品添加材として
も特に限定されず、各種のものが広い範囲で使用
出来、たとえば小麦粉、食物繊維素、大豆粉等を
具体例として例示出来る。また錠剤、丸剤、顆粒
状に賦形する際に使用される添加材としても従来
からこの種分野に於いて使用されて来たものがい
ずれも使用出来、たとえば乳糖、ブドウ糖、澱
粉、等を具体例として挙げることが出来る。
以下に本発明の相乗効果をより明瞭にするため
の実験例と本発明の具体例たる実施例を示す。
〔実験例〕
６週令の雄ラツトを５つの群に分け、夫々の群
につき６匹づつの雄ラツトに各群毎に次の割合で
調製した精製飼料を１日10gづつあたえて飼育
し、30日後、60日後、90日後の各群の各ラツトの
体重を測定した。
１群：α−サイクロデキストリン……15重量％
γ−リノレン酸 ……０〃 〃
２群：α−サイクロデキストリン……０重量％
γ−リノレン酸 ……0.5〃 〃
３群：α−サイクロデキストリン
……14.5重量％
γ−リノレン酸 ……0.5〃 〃
４群：α−サイクロデキストリン
……14.0重量％
γ−リノレン酸 ……1.0〃 〃
５群：α−サイクロデキストリン……０重量％
γ−リノレン酸 ……０〃 〃
但し各群１〜５に於いては、上記各化合物を所
定量含有せしめた精製飼料を所定量供飼したもの
である。
この結果を下記第１〜５表に示す。但し表中数
値はｇを表す。
[Industrial Field of Application] The present invention relates to a slimming food. [Prior art] Cyclodextrin has three types of isomers due to differences in their molecular structures.
Three isomers exist: cyclodextrin, β-cyclodextrin, and γ-cyclodextrin. These cyclodextrins have been used as food materials for a long time.
In particular, β-cyclodextrin is used in various applications based on its inclusion effect, such as taste improvers and powdered alcohol. However, since β-cyclodextrin is a digestible substance and is absorbed from the small intestine of the human body, it tends to be overnourished, making it extremely unsuitable as a material for slimming foods. Recently, γ, a type of cyclodextrin,
- It was discovered that cyclodextrin is difficult to digest by human digestive enzymes, and it was announced that it could be used as a material for slimming foods. Subsequently, it was discovered that this α-cyclodextrin has the ability to specifically and selectively adsorb and excrete free fatty acids within the digestive tract. On the other hand, γ-linolenic acid has been well known for a long time as a substance that has a fat metabolic effect, and is also known as a substance suitable for maintaining various health conditions, such as being effective in regulating cholesterol levels and blood pressure. . [Objective and Summary of the Invention] The present inventor has been conducting research on slimming foods, and in this research, among the many compounds effective in preventing various types of obesity, α-cyclodextrin and γ - It has been discovered that when used in combination with linolenic acid, the synergistic effect of these effects exerts a remarkable effect on preventing obesity and weight gain, and it has been confirmed that the food is extremely suitable as a slimming food. I was able to complete it. That is, the present invention relates to a slimming food containing α-cyclodextrin and γ-linolenic acid. [Configuration of the Invention] The slimming food of the present invention preferably contains α-cyclodextrin and γ-linolenic acid, preferably 0.5 to 10 parts by weight, particularly preferably 3 to 4 parts by weight, of the latter per 100 parts by weight of the former. It is what it is. As the α-cyclodextrin used in the present invention, any conventionally known α-cyclodextrin can be used. This α-cyclodextrin may be used alone, or a material containing it may be used. As the γ-linolenic acid used in the present invention, it may be used alone, or a component or substance containing it, such as evening primrose oil, may be used. In the present invention, it is essential to use the above-mentioned two types of compounds in combination, and the synergistic action of these two compounds exhibits an extremely excellent anti-obesity and anti-weight gain effect. This synergistic effect is particularly exhibited in a proportion of 0.5 to 10 parts by weight of γ-linolenic acid, particularly preferably 3 to 4 parts by weight, per 100 parts by weight of α-cyclodextrin. This excellent synergistic effect is very clear from the experimental examples described later. In the present invention, α-cyclodextrin and γ-linolenic acid are contained in various foods or food additives in a predetermined ratio, or both are added together with various conventionally known additives as necessary. It may be formed into various shapes such as tablets, pills, and granules. The foods or food additives to be included are not particularly limited, and a wide variety of materials can be used, such as wheat flour, dietary fiber, soybean flour, etc. as specific examples. In addition, any additives that have traditionally been used in this field can be used when shaping into tablets, pills, or granules, such as lactose, glucose, starch, etc. This can be cited as a specific example. Experimental examples and specific examples of the present invention will be shown below to clarify the synergistic effect of the present invention. [Experimental example] Six-week-old male rats were divided into 5 groups, and 6 male rats in each group were fed 10 g of purified feed per day prepared at the following ratio for each group. The body weight of each rat in each group was measured after 30, 60, and 90 days. Group 1: α-cyclodextrin…15% by weight γ-linolenic acid…0〃 Group 2: α-cyclodextrin…0% by weight γ-linolenic acid……0.5〃〃 Group 3: α-cyclodextrin
...14.5% by weight γ-linolenic acid ...0.5 〃 Group 4: α-cyclodextrin
...14.0% by weight γ-linolenic acid ...1.0〃 〃 Group 5: α-cyclodextrin ...0% by weight γ-linolenic acid ...0〃 〃 However, in each group 1 to 5, each of the above compounds A predetermined amount of purified feed containing a predetermined amount was fed. The results are shown in Tables 1 to 5 below. However, the numerical values in the table represent g.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
上記第１〜５表の結果から第５群のα−サイク
ロデキストリン並びにγ−リノレン酸の両者を全
く含まない精製飼料を使用した場合の90日後に於
ける体重を100％とすると、第１〜４群の90日後
に於ける各ラツトの平均体重は夫々次の通りとな
り、また平均体重減少割合は下記の通りとなる。[Table] Based on the results of Tables 1 to 5 above, if the body weight after 90 days is taken as 100% when purified feed containing neither α-cyclodextrin nor γ-linolenic acid in Group 5 is used, The average body weight of each rat after 90 days in Groups 1 to 4 is as follows, and the average weight loss rate is as follows.
実施例 １
α−サイクロデキストリン20重量部、γ−リノ
レン酸９重量％を含む月見草油10重量部を乳糖
100重量部に配合し顆粒剤として痩身用食品を調
製した。
実施例 ２
α−サイクロデキストリン30重量部、γ−リノ
レン酸９重量部を含む月見草油10重量部を乳糖、
ブドウ糖並びに天然果汁粉末と共に混合し、常法
に従つて錠剤となした。
〔発明の効果〕
本発明の痩身用食品に於いてはα−サイクロデ
キストリンとγ−リノレン酸とを含有しているの
で、これ等両者の相乗作用により極めて優れた肥
満防止または体重防止効果を発揮する。このため
痩身用としてて極めて優れた食品となり、肥満ま
たは体重過剰に基づく各種疾病の予防に極めて有
効である。
Example 1 10 parts by weight of evening primrose oil containing 20 parts by weight of α-cyclodextrin and 9% by weight of γ-linolenic acid was added to lactose.
A slimming food was prepared by blending 100 parts by weight as granules. Example 2 10 parts by weight of evening primrose oil containing 30 parts by weight of α-cyclodextrin and 9 parts by weight of γ-linolenic acid was added to lactose,
It was mixed with glucose and natural fruit juice powder and made into tablets according to a conventional method. [Effects of the Invention] Since the slimming food of the present invention contains α-cyclodextrin and γ-linolenic acid, the synergistic effect of these two products exerts an extremely excellent obesity prevention or weight prevention effect. do. Therefore, it is an extremely excellent food for slimming, and is extremely effective in preventing various diseases caused by obesity or overweight.
Claims (1)
とを含有して成る痩身用食品。 ２ α−サイクロデキストリン100重量部に対し
てγ−リノレン酸が0.5〜10重量部の割合で含有
されて成る特許請求の範囲第１項に記載の痩身用
食品。[Claims] 1. A slimming food comprising α-cyclodextrin and γ-linolenic acid. 2. The slimming food according to claim 1, which contains 0.5 to 10 parts by weight of γ-linolenic acid to 100 parts by weight of α-cyclodextrin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60149725A JPS6211072A (en) | 1985-07-08 | 1985-07-08 | Fat-reducing food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60149725A JPS6211072A (en) | 1985-07-08 | 1985-07-08 | Fat-reducing food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6211072A JPS6211072A (en) | 1987-01-20 |
| JPS6244905B2 true JPS6244905B2 (en) | 1987-09-24 |
Family
ID=15481444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60149725A Granted JPS6211072A (en) | 1985-07-08 | 1985-07-08 | Fat-reducing food |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6211072A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6281310A (en) * | 1985-10-02 | 1987-04-14 | Agency Of Ind Science & Technol | Medicinal drink containing gamma-linolenic acid |
| JPH0813257B2 (en) * | 1992-11-25 | 1996-02-14 | 日成興産株式会社 | Slimming food |
| PL220776B1 (en) * | 2002-08-19 | 2016-01-29 | Soho Flordis Internat Pty Ltd | The use of α-cyclodextrin for the manufacture of a medicament for reducing diarrhea |
| EP1447014A1 (en) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Method for reducing the glycemic index for food |
| EP1447013A1 (en) * | 2003-02-14 | 2004-08-18 | Wacker-Chemie GmbH | Method for reducing the glycemic index of food |
| US7105195B2 (en) | 2003-07-25 | 2006-09-12 | General Mills, Inc. | Reduced trans fat product |
| JP2013521796A (en) | 2010-03-13 | 2013-06-13 | イーストポンド・ラボラトリーズ・リミテッド | Fat binding composition |
-
1985
- 1985-07-08 JP JP60149725A patent/JPS6211072A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6211072A (en) | 1987-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5262167A (en) | Edible, non-baked low moisture cholestyramine composition | |
| AU2004260662B2 (en) | Reduced trans fat product | |
| US5268367A (en) | Composition and method for lowering blood level of LDL-cholesterol | |
| CA1094451A (en) | Method of controlling fecal output and compositions therefor | |
| DE2629773A1 (en) | BRAN AND PECTIN PRODUCT AND THE METHOD OF MANUFACTURING IT | |
| Bagula et al. | Tamarind seeds: chemistry, technology, applications and health benefits: A review | |
| JPS6244905B2 (en) | ||
| Alsuhaibani | Biochemical and biological study of biscuit fortified with apple powder | |
| JPH07115934A (en) | Diet food | |
| JPS6094912A (en) | Body neutral fat reducing agent | |
| DE69918929T2 (en) | Polysaccharide for reducing the psyllium-induced viscosity, and foods containing psyllium and this polysaccharide | |
| JP2510943B2 (en) | Slimming food | |
| DE102020125054A1 (en) | Use of an activated apple fiber containing pectin for the manufacture of products | |
| JPH0813257B2 (en) | Slimming food | |
| JPH07115935A (en) | Diet food | |
| JPH06153861A (en) | Flesh-reducing food | |
| JP4502533B2 (en) | A method for producing an apple fiber stock solution, a method for producing a modified pectin powder using the stock solution, and a drink using the apple fiber stock solution. | |
| JP2605208B2 (en) | Slimming food | |
| JPH11147828A (en) | Cholesterol and lipid absorption inhibitors | |
| EP4185123A1 (en) | Use of an activated carrot fiber for producing products | |
| JP7518617B2 (en) | Gelatin-containing composition and method for suppressing moisture absorption | |
| KR101718724B1 (en) | Method for Manufacturing Cheese Snack Food | |
| JPH0376557A (en) | Freeze-dried bean curd | |
| JP2024180038A (en) | Oral Compositions | |
| JPH0940574A (en) | Diet composition |